PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Extended-release medication offers promise for treating alcohol, opioid dependence

2014-05-14
(Press-News.org) PORTLAND, Ore. – A comparatively new form of a medication for alcohol and opioid dependence that's injected once a month instead of taken orally once a day appears to be significantly more effective than some other medications – because more patients actually continue the prescribed regimen.

The findings, published in the Journal of Substance Abuse Treatment by researchers from Oregon State University and other institutions, offer support for a wider use of medications that may help reduce or prevent substance abuse and related hospital admissions.

The cost savings could offset the cost of the medication, researchers said.

In the past, there has been fairly low use of medications to treat alcohol and opioid dependence. Several treatment options are available, with differing mechanisms of action, and they generally work to reduce the pleasurable feelings associated with drug and alcohol use, thereby discouraging the use of them.

The medication in the study that was found to be more effective than some past approaches was extended-release Naltrexone, which is administered once a month by injection in a medical setting. The research was supported by Alkermes, Inc., the manufacturer of that medication.

"Some of these medications are opioid antagonists, which reduce the euphoric effects of alcohol and some drugs," said Dan Hartung, an associate professor in the Oregon State University/Oregon Health & Science University College of Pharmacy, and lead author on the study.

"Historically, oral medications for substance abuse have not often been prescribed or found to have a high degree of success, mostly because patients stopped taking them," Hartung said. "But there are patients who are committed to treating their problems and data showed that they clearly appear to have success with extended-release Naltrexone, which is administered just once a month."

The issue may be of increased importance, experts said, because of health and prescription drug coverage that is now being made available through the Affordable Care Act. It may make such medications available to many people who previously did not have access to them, and in the process achieve some goals of reducing hospital admissions.

The new meta-analysis combined findings from five other papers, comprising a total of 1,565 patients who received extended-release Naltrexone compared to other therapies for six months, among nearly 60,000 overall patients – the only comprehensive analysis of its type that has been completed.

It found that even though extended-release Naltrexone is expensive – about $1,100 a month – the total health care utilization and costs were generally lower for patients taking it, compared to those using other alcohol-dependence treatments.

They found that significant savings were produced by fewer days of detoxification facility use and inpatient utilization.

Alcohol and drug use disorders affect more than 21 million Americans, the researchers noted in their study – or about 8 percent of the nation's population. Research in New York found that substance abuse more than doubled the number of preventable hospital re-admissions. But despite this, treatment of alcohol dependence with medications ranks the lowest among 25 health and behavioral conditions.

"There has always been some reluctance on the part of health care practitioners, as well as the patients they are treating, to use prescription medication to treat a substance abuse problem," Hartung said. "Medication-assisted therapy is underutilized. With more people having access to these medications, now would be a good time to do further research on the comparative efficacy and use of them."

Although most studies of extended-release Naltrexone have been six months in duration, longer-term data suggest effectiveness is maintained for longer durations of therapy. Very limited research has been done comparing the efficacy of various drugs for these purposes.

Nationally, even at addiction treatment centers, only 24 percent used pharmacotherapy for alcohol dependence and 34 percent for opioid dependence. Barriers to use include financing, concerns about cost, medical staffing, education and attitudes.

"Given rising pressures to reduce potentially preventable hospital readmissions and other reducible cost and morbidity causes," the researchers wrote in their conclusion, "the optimization of patient care and management of resources warrant systemic change in the delivery of addiction treatment, in the advancing era of health care reform."

INFORMATION:

Editor's Note: The study this story is based on is available in ScholarsArchive@OSU: http://bit.ly/1i9n2tD


ELSE PRESS RELEASES FROM THIS DATE:

Texas A&M-led study shows how 'body clock' dysregulation underlies obesity, more

2014-05-14
COLLEGE STATION – A team of Texas A&M University System scientists have investigated how "body clock dysregulation" might affect obesity-related metabolic disorders. The team was led by Dr. Chaodong Wu, associate professor in the department of nutrition and food sciences of Texas A&M's College of Agriculture and Life Sciences, and Dr. David Earnest, professor in the department of neuroscience and experimental therapeutics, Texas A&M Health Science Center. Study results were published recently on the Journal of Biological Chemistry website at http://www.jbc.org/content/early/2014/04/25/jbc.M113.539601. "Animal ...

A better way to treat ACE inhibitor angioedema in the ED

2014-05-14
CINCINNATI—Investigators at the University of Cincinnati have found a safe and effective treatment for life-threatening angioedema attacks in the emergency department. In angioedema, patients experience a rapid swelling of the skin and subcutaneous tissues—which, in some cases, can lead to airway obstruction and suffocation. Physicians usually treat angioedema like an allergic reaction with corticosteroids and antihistamines. But that therapy doesn't always work for another version of the condition, thought to be caused by taking a class of drugs known as ACE inhibitors. ...

Obesity associated with longer hospital stays, higher costs in total knee replacement patients

2014-05-14
ROSEMENT, Ill.─ Obesity is associated with longer hospital stays and higher costs in total knee replacement (TKR) patients, independent of whether or not the patient has an obesity-related disease or condition (comorbidity), according to a new study published in the Journal of Bone and Joint Surgery (JBJS). More than half of TKR patients have a body mass index (BMI) within the obesity range (greater than 30 kg/m²), which has been linked to a higher risk for related comorbidities such as diabetes, hypertension, osteoarthritis; and in some studies, to higher medical ...

California Central Valley groundwater depletion slowly raises Sierra Nevada mountains

California Central Valley groundwater depletion slowly raises Sierra Nevada mountains
2014-05-14
Winter rains and summer groundwater pumping in California's Central Valley make the Sierra Nevada and Coast Mountain Ranges sink and rise by a few millimeters each year, creating stress on the state's faults that could increase the risk of an earthquake. Gradual depletion of the Central Valley aquifer, because of groundwater pumping, also raises these mountain ranges by a similar amount each year--about the thickness of a dime--with a cumulative rise over the past 150 years of up to 15 centimeters (6 inches), according to calculations by a team of geophysicists. The ...

Nanowire bridging transistors open way to next-generation electronics

Nanowire bridging transistors open way to next-generation electronics
2014-05-14
VIDEO: UC Davis engineer Saif Islam explains how growing semiconductor nano-sized wires and bridges on silicon can lead to a new generation of robust electronic devices. Click here for more information. A new approach to integrated circuits, combining atoms of semiconductor materials into nanowires and structures on top of silicon surfaces, shows promise for a new generation of fast, robust electronic and photonic devices. Engineers at the University of California, Davis, have ...

Societies publish recommendations to guide minimally invasive valve therapy programs for patients

2014-05-14
WASHINGTON, D.C., BEVERLY, MA, and CHICAGO (May 15, 2014) – As minimally invasive therapies are increasingly used to treat diseased heart valves, newly published recommendations provide guidance on best practices for providing optimal care for patients. The document released today offers first-time guidance from four professional medical associations on developing and maintaining a transcatheter mitral valve therapy program, emphasizing collaboration between interventional cardiologists and cardiac surgeons. The document is an important step toward achieving consistent, ...

Inhibiting protein family helps mice survive radiation exposure, Stanford study finds

2014-05-14
STANFORD, Calif. - Tinkering with a molecular pathway that governs how intestinal cells respond to stress can help mice survive a normally fatal dose of abdominal radiation, according to a new study by researchers at the Stanford University School of Medicine. Because the technique is still partially effective up to 24 hours after exposure, the study suggests a possible treatment for people unintentionally exposed to large amounts of radiation, such as first responders at the Chernobyl nuclear disaster in 1986. "We were very surprised by the amount of protection the ...

Antidepressant may slow Alzheimer's disease

Antidepressant may slow Alzheimers disease
2014-05-14
A commonly prescribed antidepressant can reduce production of the main ingredient in Alzheimer's brain plaques, according to new research at Washington University School of Medicine in St. Louis and the University of Pennsylvania. The findings, in mice and people, are published May 14 in Science Translational Medicine. They support preliminary mouse studies that evaluated a variety of antidepressants. Brain plaques are tied closely to memory problems and other cognitive impairments caused by Alzheimer's disease. Stopping plaque buildup may halt the disastrous mental ...

Can anti-depressants help prevent Alzheimer's disease?

Can anti-depressants help prevent Alzheimers disease?
2014-05-14
PHILADELPHIA – A University of Pennsylvania researcher has discovered that the common selective serotonin reuptake inhibitor (SSRI) citalopram arrested the growth of amyloid beta, a peptide in the brain that clusters in plaques that are thought to trigger the development of Alzheimer's disease (AD). Penn, in collaboration with investigators at Washington University, tested the drug's effects on the brain interstitial fluid (ISF) in plaque-bearing mice and the cerebrospinal fluid (CSF) of healthy human subjects to draw its conclusions, which are detailed in the new issue ...

Hitting a moving target

Hitting a moving target
2014-05-14
LA JOLLA, CA—May 14, 2014—A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus—thanks to the diversity of targets the site presents to the human immune system. The finding, from a study led by scientists at The Scripps Research Institute (TSRI), is likely to influence future designs for HIV vaccines and antibody-based therapies. "We found, for example, that if the virus tries to escape from an antibody directed at that site by eliminating one of its sugars, the antibody often ...

LAST 30 PRESS RELEASES:

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’

Condo-style living helps keep the peace inside these ant plants

Climate change action could dramatically limit rising UK heatwave deaths

Annual heat-related deaths projected to increase significantly due to climate and population change

Researchers discover new way cells protect themselves from damage

[Press-News.org] Extended-release medication offers promise for treating alcohol, opioid dependence